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Background: Several reports have demonstrated the amount of contrast media volume (CMV) was a predictor of contrast induced nephropathy 
(CIN). The previous report suggested that the ratio of the CMV to the creatinine clearance has been shown to correlate with occurrence of CIN. In the 
case of renal dysfunction , estimated glomerular filtration rate (eGFR) tends to reflect the true renal function compared to creatinine clearance. The 
aim of this study was to evaluate the appropriate CMV in the patients with chronic kidney disease (CKD).
Methods: CIN was defined as previously reported (absolute (≥0.5 mg/dl) or relative (≥25%) increase in serum creatinine levels compared to 
baseline values). Receiver-operator characteristic methods were used to identify the appropriate CMV/eGFR ratio.
Results: In 3044 consecutive patients who underwent Percutaneous Coronary Intervention in our institution. We evaluated baseline and 48h post 
procedural creatinine levels in 1256 patients with CKD (stage 3&4; eGFR 15-59 ml/min/1.73m2) and calculated the ratio of CMV to the eGFR 
(CMV/eGFR) . CIN occurred in 7.8% (99/1256). CMV/eGFR ratio in the patients who developed CIN was significant higher than that in the patient 
who did not developed CIN (5.54 vs. 4.00, p<0.0001). The Receiver-operator characteristic analysis indicated that CMV/eGFR ratio of 5.35 was a 
fair discriminator for CIN (AUC 0.630, sensitivity 77%, specificity 47%). Multivariate logistic regression revealed that significant predictors of CIN 
were CMV/eGFR ratio (OR 0.38, 95%CI 0.39-0.61, p<0.0001) and acute myocardial infarction (OR 3.45, 95%CI 1.82-5.09, p<0.0001).
Conclusions: In this study, a CMV/eGFR ratio > 5.35 was a significant and independent predictor of CIN in patients with CKD. To prevent CIN, 
careful attention should be paid to minimizing the CMV used in these patients.
